Loss of SNAP‐25 and rabphilin 3a in sensory‐motor cortex in Huntington’s disease

Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG‐expansion in the gene encoding the protein huntingtin. The disease is characterized by progressive motor disturbances, cognitive defects, dementia, and weight loss. Using western blotting and immunohistochemistry we have assessed the expression levels and patterns of a number of proteins involved in neurotransmitter release in post‐mortem frontal cortex samples from 10 HD cases with different disease grades. We report a loss of the soluble N‐ethylmaleimide‐sensitive factor attachment protein receptor (SNARE) protein, synaptosome‐associated protein 25 (SNAP 25) in HD brains of grades I–IV. Moreover, in brains of grade III and IV we found a reduction in rabphilin 3a, a protein involved in vesicle docking and recycling. These losses appear to be specific and not due to a general loss of synapses in the HD cortex. Thus, levels of synaptobrevin II, syntaxin 1, rab3a or synaptophysin are unaltered in the same patient samples. SNAP 25 and rabphilin 3a are crucial for neurotransmitter release. Therefore, we suggest that a deficient pre‐synaptic transmitter release may underlie some of the symptoms of HD.

[1]  S. Snyder,et al.  A huntingtin-associated protein enriched in brain with implications for pathology , 1995, Nature.

[2]  T. Südhof,et al.  SNARE Function Analyzed in Synaptobrevin/VAMP Knockout Mice , 2001, Science.

[3]  E. Seeberg,et al.  Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro , 2004, Molecular and Cellular Biology.

[4]  Josep M. Canals,et al.  Mutant huntingtin Impairs the Post-Golgi Trafficking of Brain-Derived Neurotrophic Factor But Not Its Val66Met Polymorphism , 2006, The Journal of Neuroscience.

[5]  M. Graham,et al.  Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis , 2006, Nature Neuroscience.

[6]  Carlos Cepeda,et al.  Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease , 2003, The Journal of Neuroscience.

[7]  P. Reddy,et al.  Polyglutamine-expanded Huntingtin Promotes Sensitization of N-Methyl-d-aspartate Receptors via Post-synaptic Density 95* , 2001, The Journal of Biological Chemistry.

[8]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[9]  Joseph B. Martin.  Huntington's disease , 1984, Neurology.

[10]  P. Brundin,et al.  Synaptic dysfunction in Huntington’s disease: a new perspective , 2005, Cellular and Molecular Life Sciences CMLS.

[11]  Patrik Brundin,et al.  Huntington's disease: a synaptopathy? , 2003, Trends in molecular medicine.

[12]  L. Donald Partridge,et al.  Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis , 2002, Nature Neuroscience.

[13]  J. Conner,et al.  Anterograde transport of brain-derived neurotrophic factor and its role in the brain , 1997, Nature.

[14]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[15]  T. Sasaki,et al.  Involvement of rabphilin-3A in Ca2+-dependent exocytosis from PC12 cells. , 1996, Biochemical and biophysical research communications.

[16]  Fabrice P Cordelières,et al.  Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules , 2004, Cell.

[17]  P. Greengard,et al.  Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Thorsten Lang,et al.  Membrane fusion. , 2002, Current opinion in cell biology.

[19]  P. Brundin,et al.  Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice , 2002, Neurobiology of Disease.

[20]  A Weindl,et al.  Changes of NMDA Receptor Subunit (NR1, NR2B) and Glutamate Transporter (GLT1) mRNA Expression in Huntington's Disease—An In Situ Hybridization Study , 1997, Journal of neuropathology and experimental neurology.

[21]  R. Roos,et al.  Cholinergic neuronal defect without cell loss in Huntington's disease. , 2006, Human molecular genetics.

[22]  H. Kremer,et al.  The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease , 1991, Neuroscience Letters.

[23]  Xiao-Jiang Li,et al.  Huntingtin-protein interactions and the pathogenesis of Huntington's disease. , 2004, Trends in genetics : TIG.

[24]  K. Kaibuchi,et al.  Rabphilin-3A, a putative target protein for smg p25A/rab3A p25 small GTP-binding protein related to synaptotagmin , 1993, Molecular and cellular biology.

[25]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[26]  J. Olson,et al.  Regional and cellular gene expression changes in human Huntington's disease brain. , 2006, Human molecular genetics.

[27]  K. Kaibuchi,et al.  Two functionally different domains of rabphilin-3A, Rab3A p25/smg p25A-binding and phospholipid- and Ca(2+)-binding domains. , 1993, The Journal of biological chemistry.

[28]  Scott T. Brady,et al.  Neuropathogenic Forms of Huntingtin and Androgen Receptor Inhibit Fast Axonal Transport , 2003, Neuron.

[29]  B. Harper.  Huntington Disease , 2005, Journal of the Royal Society of Medicine.

[30]  Blair R. Leavitt,et al.  Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.

[31]  Y. Takai,et al.  Evidence That the Rab3a-binding Protein, Rabphilin3a, Enhances Regulated Secretion. , 1995, The Journal of Biological Chemistry.

[32]  F. Walker.  Huntington's disease , 2007, The Lancet.

[33]  T. Yamamoto,et al.  Rabphilin-3A is associated with synaptic vesicles through a vesicle protein in a manner independent of Rab3A. , 1994, The Journal of biological chemistry.

[34]  A. Morton,et al.  Abnormalities in the synaptic vesicle fusion machinery in Huntington’s disease , 2001, Brain Research Bulletin.

[35]  R. Yasuda,et al.  Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model. , 2003, Brain : a journal of neurology.

[36]  S. W. Davies,et al.  Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[37]  C A Ross,et al.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. , 2000, Human molecular genetics.

[38]  R. Jackisch,et al.  Mice transgenic for exon 1 of Huntington's disease: properties of cholinergic and dopaminergic pre‐synaptic function in the striatum , 2003, Journal of neurochemistry.

[39]  T. Südhof,et al.  Rabphilin regulates SNARE‐dependent re‐priming of synaptic vesicles for fusion , 2006, The EMBO journal.

[40]  K. Dear,et al.  Early cognitive deficits in Swedish gene carriers of Huntington's disease. , 2007, Neuropsychology.

[41]  D. Tagle,et al.  PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. , 2002, Human molecular genetics.

[42]  K. Baer,et al.  Immunohistochemical staining of post-mortem adult human brain sections , 2006, Nature Protocols.

[43]  S. Hersch,et al.  HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. , 2002, Human molecular genetics.

[44]  S. W. Davies,et al.  Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  L. A. Swayne,et al.  Aggregate-centered redistribution of proteins by mutant huntingtin. , 2007, Biochemical and biophysical research communications.

[46]  Richard G. Brusch,et al.  Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.

[47]  T. Sasaki,et al.  Rabphilin-3A: A Multifunctional Regulator of Synaptic Vesicle Traffic , 1998, The Journal of general physiology.

[48]  P. De Camilli,et al.  The stimulatory effect of rabphilin 3a on regulated exocytosis from insulin-secreting cells does not require an association-dissociation cycle with membranes mediated by Rab 3. , 1997, European journal of cell biology.

[49]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[50]  P. Brundin,et al.  Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction , 2005, Neurobiology of Disease.